Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
- PMID: 27090302
- PMCID: PMC4879188
- DOI: 10.1038/mp.2016.46
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
Abstract
The inflammasome is hypothesized to be a key mediator of the response to physiological and psychological stressors, and its dysregulation may be implicated in major depressive disorder. Inflammasome activation causes the maturation of caspase-1 and activation of interleukin (IL)-1β and IL-18, two proinflammatory cytokines involved in neuroimmunomodulation, neuroinflammation and neurodegeneration. In this study, C57BL/6 mice with genetic deficiency or pharmacological inhibition of caspase-1 were screened for anxiety- and depressive-like behaviors, and locomotion at baseline and after chronic stress. We found that genetic deficiency of caspase-1 decreased depressive- and anxiety-like behaviors, and conversely increased locomotor activity and skills. Caspase-1 deficiency also prevented the exacerbation of depressive-like behaviors following chronic stress. Furthermore, pharmacological caspase-1 antagonism with minocycline ameliorated stress-induced depressive-like behavior in wild-type mice. Interestingly, chronic stress or pharmacological inhibition of caspase-1 per se altered the fecal microbiome in a very similar manner. When stressed mice were treated with minocycline, the observed gut microbiota changes included increase in relative abundance of Akkermansia spp. and Blautia spp., which are compatible with beneficial effects of attenuated inflammation and rebalance of gut microbiota, respectively, and the increment in Lachnospiracea abundance was consistent with microbiota changes of caspase-1 deficiency. Our results suggest that the protective effect of caspase-1 inhibition involves the modulation of the relationship between stress and gut microbiota composition, and establishes the basis for a gut microbiota-inflammasome-brain axis, whereby the gut microbiota via inflammasome signaling modulate pathways that will alter brain function, and affect depressive- and anxiety-like behaviors. Our data also suggest that further elucidation of the gut microbiota-inflammasome-brain axis may offer novel therapeutic targets for psychiatric disorders.
Figures





Similar articles
-
Gut microbiota dysbiosis contributes to depression-like behaviors via hippocampal NLRP3-mediated neuroinflammation in a postpartum depression mouse model.Brain Behav Immun. 2024 Jul;119:220-235. doi: 10.1016/j.bbi.2024.04.002. Epub 2024 Apr 8. Brain Behav Immun. 2024. PMID: 38599497
-
Fecal microbiota transplantation from chronic unpredictable mild stress mice donors affects anxiety-like and depression-like behavior in recipient mice via the gut microbiota-inflammation-brain axis.Stress. 2019 Sep;22(5):592-602. doi: 10.1080/10253890.2019.1617267. Epub 2019 May 24. Stress. 2019. PMID: 31124390
-
The Microbiota-Inflammasome Hypothesis of Major Depression.Bioessays. 2018 Sep;40(9):e1800027. doi: 10.1002/bies.201800027. Epub 2018 Jul 13. Bioessays. 2018. PMID: 30004130 Free PMC article. Review.
-
Probiotic consumption during puberty mitigates LPS-induced immune responses and protects against stress-induced depression- and anxiety-like behaviors in adulthood in a sex-specific manner.Brain Behav Immun. 2019 Oct;81:198-212. doi: 10.1016/j.bbi.2019.06.016. Epub 2019 Jun 15. Brain Behav Immun. 2019. PMID: 31212008
-
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?Prog Neurobiol. 2020 Aug;191:101806. doi: 10.1016/j.pneurobio.2020.101806. Epub 2020 May 28. Prog Neurobiol. 2020. PMID: 32473843 Review.
Cited by
-
Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders.Neuropsychopharmacology. 2017 Jan;42(1):36-45. doi: 10.1038/npp.2016.125. Epub 2016 Jul 14. Neuropsychopharmacology. 2017. PMID: 27412959 Free PMC article. Review.
-
The Effects of Stress and Diet on the "Brain-Gut" and "Gut-Brain" Pathways in Animal Models of Stress and Depression.Int J Mol Sci. 2022 Feb 11;23(4):2013. doi: 10.3390/ijms23042013. Int J Mol Sci. 2022. PMID: 35216133 Free PMC article. Review.
-
The "Entourage Effect": Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders.Curr Neuropharmacol. 2020;18(2):87-96. doi: 10.2174/1570159X17666190903103923. Curr Neuropharmacol. 2020. PMID: 31481004 Free PMC article. Review.
-
Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial.J Psychiatry Neurosci. 2023 Jan 18;48(1):E23-E33. doi: 10.1503/jpn.220117. Print 2023 Jan-Feb. J Psychiatry Neurosci. 2023. PMID: 36653035 Free PMC article. Clinical Trial.
-
The Antidepressant Effect of Deoiled Sunflower Seeds on Chronic Unpredictable Mild Stress in Mice Through Regulation of Microbiota-Gut-Brain Axis.Front Nutr. 2022 Jul 1;9:908297. doi: 10.3389/fnut.2022.908297. eCollection 2022. Front Nutr. 2022. PMID: 35859751 Free PMC article.
References
-
- Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012; 36: 764–785. - PubMed
-
- Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999; 4: 317–327. - PubMed
-
- Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001; 11: 203–208. - PubMed
-
- Kokai M, Kashiwamura S, Okamura H, Ohara K, Morita Y. Plasma interleukin-18 levels in patients with psychiatric disorders. J Immunother 2002; 25(Suppl 1): S68–S71. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous